Trupanion, Inc. (NASDAQ:TRUP) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Trupanion, Inc. (NASDAQ:TRUP) have earned an average recommendation of “Moderate Buy” from the seven ratings firms that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $40.67.

A number of analysts have recently weighed in on the stock. Bank of America boosted their price objective on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Northland Securities upped their price target on shares of Trupanion from $35.00 to $45.00 and gave the company a “market perform” rating in a report on Thursday, September 19th. Stifel Nicolaus lifted their price objective on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 23rd. Piper Sandler raised their target price on Trupanion from $30.00 to $38.00 and gave the company a “neutral” rating in a report on Friday, August 9th. Finally, William Blair began coverage on Trupanion in a report on Friday, July 19th. They set an “outperform” rating for the company.

Trupanion Stock Down 0.0 %

TRUP opened at $42.70 on Monday. The company has a market capitalization of $1.80 billion, a PE ratio of -66.72 and a beta of 1.74. The business has a 50-day moving average of $41.43 and a 200-day moving average of $32.20. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.63 and a quick ratio of 1.63. Trupanion has a fifty-two week low of $19.14 and a fifty-two week high of $49.14.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.04. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The company had revenue of $314.80 million for the quarter, compared to analyst estimates of $309.33 million. During the same period last year, the company earned ($0.33) earnings per share. The business’s revenue was up 16.3% compared to the same quarter last year. Equities research analysts forecast that Trupanion will post -0.34 EPS for the current fiscal year.

Insider Transactions at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 624 shares of Trupanion stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $46.54, for a total transaction of $29,040.96. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now owns 99,984 shares in the company, valued at approximately $4,647,256.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Fawwad Qureshi sold 624 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $46.54, for a total transaction of $29,040.96. The disclosure for this sale can be found here. In the last three months, insiders sold 8,764 shares of company stock valued at $405,238. Company insiders own 5.50% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of TRUP. Headlands Technologies LLC acquired a new stake in shares of Trupanion in the second quarter valued at $162,000. Blueshift Asset Management LLC acquired a new position in shares of Trupanion during the fourth quarter worth approximately $220,000. Oppenheimer Asset Management Inc. bought a new stake in shares of Trupanion during the second quarter worth approximately $235,000. Bayesian Capital Management LP acquired a new position in shares of Trupanion in the 1st quarter valued at $253,000. Finally, Capstone Investment Advisors LLC bought a new stake in Trupanion in the first quarter valued at about $269,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.